ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M. Eichhoff, Mitchell P. Levesque, Nina Zila et al.|Cancer Research|2023Cited by 24
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosisBenjamin Loos, Lukas Sommer, Adrián Salas-Bastos et al.|Cell Death and Disease|2024Cited by 11
Suppl. Figure S14 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M. Eichhoff, Mitchell P. Levesque, Corinne I. Stoffel et al.|Unknown|2023Cited by 0